4-Ethoxypyrimidine → (RS)-S-(3-{[5-bromo-4-(methoxy)pyrimidin-2-yl]amino}phenyl)-S-methylsulfoximide

반응식

C(OC([N:6]=[S:7]([C:10]1[CH:15]=[CH:14][CH:13]=[C:12]([NH:16][C:17]2[N:22]=[C:21]([O:23][CH3:24])[C:20]([Br:25])=[CH:19][N:18]=2)[CH:11]=1)([CH3:9])=[O:8])=O)C.C(OC1C=CN=CN=1)C>>[Br:25][C:20]1[C:21]([O:23][CH3:24])=[N:22][C:17]([NH:16][C:12]2[CH:11]=[C:10]([S:7]([CH3:9])(=[NH:6])=[O:8])[CH:15]=[CH:14][CH:13]=2)=[N:18][CH:19]=1

참가 물질

반응물 2

HCID 122449414-Ethoxypyrimidine

HCID 57659254HCID 57659254, 화합물

생성물 1

HCID 59684680(RS)-S-(3-{[5-bromo-4-(methoxy)pyrimidin-2-yl]amino}phenyl)-S-methylsulfoximide수율 3%

실험 절차

Intermediate 14a was prepared in analogy to GP 9 by reaction of Intermediate 14 (500 mg (1.16 mmol) to give, aside a larger quantity of the corresponding 4-ethoxypyrimidine, 14 mg (3%) of the desired product.

후처리

customto give

출처 및 근거

ORD 기록: ord-b75d72e3104f4ca8996a809aae9fc2ae
출처 데이터셋: uspto-grants-2011_08
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US08003655B2

반응 노트

불러오는 중…